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Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases with no cure to this
day, and are often associated with the accumulation of amyloid plaques in the brain and other tissues in
affected individuals. The emergence of new variant Creutzfeldt–Jakob disease, an acquired TSE with a
relatively long asymptomatic incubation period and unknown prevalence or incidence, which could
potentially be iatrogenically transmitted, has prompted the need for sensitive and rapid methods of detection
of the pathology indicator, the protease-resistant prion protein (PrPSc), in tissues and on surgical
instruments. To discriminate between common tissue proteins and amyloid-rich aggregates such as those
formed by abnormal prion, we developed a quantitative thioﬂavin T/SYPRO Ruby dual staining procedure,
used in combination with episcopic differential interference contrast/epiﬂuorescence (EDIC/EF) microscopy
for rapid scanning of samples. The detection limit of this direct observation technique applied to brain
homogenates was greatly enhanced by the addition of Tween 20, as demonstrated in double-blind studies
using various proportions of ME7-infected brain mixed with normal brain homogenate. The characteristic
thioﬂavin T signal correlated with the relative amount of prion amyloid and proved at least 2-log more
sensitive than the classic Western blot using the same prepared samples. This new sensitive microscopy
procedure, which can be easily applied in instrument decontamination surveys, is likely to be more sensitive
that Western blot in practice since it does not rely on the elution of resilient PrPSc bound to the instrument
surfaces. Our study also demonstrates how interactions between prion and lipid-rich tissue homogenates
may reduce the sensitivity of such detection assays.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
Transmissible spongiform encephalopathies (TSEs) are rare, fatal
neurodegenerative diseaseswhichmayoccur in various animal species
(see reviews byBrown, 2008; Collinge, 2001; Prusiner,1998). TSEsmay
develop when the host-encoded constitutive prion protein (PrPC) is
mutated to an isoform richer in beta-pleated sheets, which is partly
resistant to proteolytic digestion. In humans, identiﬁed TSEs include
Creutzfeldt–Jakob disease (CJD), Kuru, Gerstmann–Sträussler–Schein-
ker syndrome (GSS) and fatal familial insomnia (FFI), and these have
been further classiﬁed according to their etiology (Gambetti et al.,
2003). The incidence of a genetic mutation leading to sporadic TSEs is
believed to be low (about 1 per million annually for sporadic CJD).
According to the “prion only” hypothesis, absorption of exogenous
PrPSc is sufﬁcient to trigger the post-translational refolding of
endogenous PrPC in healthy, genetically susceptible individuals, lead-
ing to an acquired form of the disease. The accumulation of protease-
resistant PrPSc in the form of amyloid plaques in tissues, particularly in
the lymphoreticular and central nervous systems, are a common
pathological feature of TSEs.
The consumption of contaminated tissues has been identiﬁed as a
route of transmission leading to acquired CJD. This horizontal trans-
mission of the disease was described in the cannibalistic Fore tribe
of Papua New Guinea in the middle of last century (see reviews by
Ironside, 2003; Collinge et al., 2006), and there is strong evidence that
the same route was implicated in the bovine spongiform encephalo-
pathy (BSE) epidemic originating from the UK during the mid 1980s,
in which case cattle were fed on reprocessed carcasses of slaughtered
contaminated animals (“meat and bone meal”), leading to the conta-
mination of an estimated 1 million animals destined to human con-
sumption (Wells et al., 1991; Anderson et al., 1996). There has been
increasing experimental evidence that various protease-resistant prion
strains are capable of crossing the species barrier (Mishra et al., 2004;
Priola and Vorberg, 2004; Foster et al., 1993), and that the ingestion of
BSE-infected beef meat is the actual cause of the so-called variant
form of CJD in humans (vCJD; Hill et al., 1997). Acquired TSEs are
characterized by a relatively long and initially asymptomatic incu-
bation period (up to 50 years for Kuru; Collinge et al., 2006) which
Journal of Microbiological Methods 77 (2009) 90–97
⁎ Corresponding author. Tel.: +44 2380592034; fax: +44 23594459.
E-mail address: R.Herve@soton.ac.uk (R. Hervé).
0167-7012/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.mimet.2009.01.017
Contents lists available at ScienceDirect
Journal of Microbiological Methods
j ourna l homepage: www.e lsev ie r.com/ locate / jmicmeth
Author's personal copy
varies depending on the nature of the infective strain, the route of
transmission, and the genetic susceptibility of the recipient. This has
led to the fear that an unknown proportion of the population who
have been eating potentially contaminated meat in the 1980s might
currently present as asymptomatic carriers of the vCJD infectious
agent, despite current statistics which indicate that the number of
deaths by vCJD peaked in 2000 and has been in decline since
(Caramelli et al., 2006; Setbon et al., 2005).
Beside transmission of the infectious agent through the ingestion
of contaminated products, bearing in mind the potential threat of vCJD
incubating in the population, a number of medical procedures are now
also considered as posing a potential risk of iatrogenic contamina-
tion with PrPSc (Pana and Jung, 2005; Lumley and Serious Hazards of
Transfusion Committee, 2008). The procedures identiﬁed at risk include
neurosurgery and eye surgery (Dinakaran and Kayarkar, 2002), and
other invasive interventions such as blood transfusion (Ironside, 2003;
Llewelyn et al., 2004; Wroe et al., 2006), endoscopy (Ponchon, 1997;
Axon et al., 2001) and dentistry (Azarpazhooh and Leake, 2006;
Whitworth, 2007). In the absence of a cure for the disease, avoidance
and precautionary measures are the only ethical option currently
available to public and private health services. PrPSc is known to be
resistant to most inactivation and decontamination protocols, and
currentmethods of neutralisation in the laboratory involve strong alkali
compounds (Jung et al., 2005), which are themselves detrimental to
most surfaces. In recent years great emphasis has been put on the
decontamination of surgical instruments as a means of preventing
iatrogenic transmission, and a number of cleaning products have been
developed and marketed for the purpose of tackling the protease-
resistant prion issue, though relatively little has been done to assess the
efﬁciency of these cleaners in a clinical context, where the turnover of
surgical instruments is high and the time to clean them is limited. We
have already reported that common methods currently available to
assess the cleanliness of surgical instruments, such as direct visual
inspection and indirect Biuret or ninhydrin chromogenic assays, are far
from being sensitive at picking up remaining contamination on
surgical stainless steel surfaces (Lipscomb et al., 2006a, 2008). We
have previously described a new microscopic technique, episcopic
differential interference contrast/epiﬂuorescence (EDIC/EF) for the
rapid and sensitive in situ detection of general protein contamination on
surgical instruments (Lipscomb et al., 2006b), and more recently we
havemodiﬁed this technique for the detection of amyloid-like proteins
using ﬂuorescent thiazole reagents (Lipscomb et al., 2007). At present
no other molecule or microorganism than PrPSc have been clearly
associated with TSEs, despite recent reports on infective tissues that
appear PrPSc-free. The presence of amyloid aggregates as those which
may be seenwith PrPSc are therefore a useful, if not the only, preclinical
indicator of a potential pathology. Since PrPSc appears to bind strongly
to surfaces, the detection of amyloid aggregates among other
proteinaceous contamination on surgical instruments might serve as
a useful tool in the prevention of iatrogenic dissemination of TSEs. In
addition, the detection of PrPSc or other amyloid aggregates in tissues
remains the best approach for clinical diagnosis of TSEs and other
amyloidoses, though this is most often performed post-mortem via
Western blot or immunohistochemistry.
Although the presence of amyloid aggregates is admittedly only a
pathological indicator and does not directly correlate with the poten-
tial infectivity of a particular sample, a sensitivemethod to ensure that
reused surgical instruments are free of general protein soil, especially
detectable amyloid-containing deposits, would be a major advance in
the prevention of potential iatrogenic contamination during surgical
procedures. Accordingly, we have developed a new dual staining pro-
cedure which allows the rapid and sensitive quantiﬁcation of amyloid
content in proteinaceous deposits. Here we show the potential of this
technique applied to the detection of the pathological amyloid aggre-
gates in sample tissues, and show how tissue lipids may be a factor
contributing to reduced sensitivity of such direct detection assays.
We also demonstrate how this method may be used to evaluate
decontamination practices using test surgical instruments spikedwith
better deﬁned test soils, in terms of protein and amyloid concentration.
2. Methods
Preparation of samples for the determination of the lowest limit of
detection of amyloidogenic prion in homogenates.
Brain homogenates from ME7-infected mice and control normal
brain homogenate (NBH; both from TSE Resource Centre, Institute
for Animal Health, Newbury, UK) were assayed and normalized to a
protein concentration of 1mgml−1 in deionisedwaterwith 0.1% (v/v)
Tween 20 (Sigma) to improve homogenisation for calibration (see
results), aliquoted and stored at−20 °C until use. On the day of each
experiment, ME7-infected homogenate and NBH stock aliquots were
mixed in various proportions (from 0 up to 100%ME7 in NBH), anony-
mised, and kept in ice until staining and observation (usually within
1 h). One sample containing NBH only was clearly labelled as “negative
control”. Surgical stainless steel tokens were thoroughly cleaned as
described previously (Lipscomb et al., 2007), and a 1 µl drop of each
anonymised sample and the negative control was applied and dried on
the tokens surface for 30 min at 37 °C prior to staining.
2.1. Dual staining procedure
We developed a dual staining protocol based on our previously
described methods for the rapid detection of general protein conta-
mination (Lipscombet al., 2006b) and the speciﬁc detectionof amyloid-
like formations on surgical instruments (Lipscomb et al., 2007), with
slight modiﬁcations. All incubations were performed at room tem-
perature, and samples were protected from direct light as much as
possible to prevent fading of the ﬂuorescent signal. A thioﬂavin T (ThT;
Sigma) working solution (0.2% w/v) was prepared shortly before use
in 0.01 M hydrochloric acid, and applied onto samples for 10 min.
Samples were washed by gentle immersion (no ﬂushing) and incu-
bated for 10 minwith 0.1% (v/v) acetic acid, followed by awash in PBS
and another wash in deionised water. SYPRO Ruby solution (SR; Invi-
trogen, UK) was then applied for 15 min, followed by 3 ﬁnal washes in
deionised water. Excess water was dried off and samples were micro-
scopically examined immediately after staining under an EDIC/EF
microscope.
2.2. Microscopy
EDIC/EF microscopy and its application for the detection of pro-
teinaceous deposits on surfaces have been described previously
(Keevil, 2003; Lipscomb et al., 2006b, 2008). Volunteers were asked
to examine each anonymous sample in two steps. Firstly, a scan of the
whole area of surgical stainless steel covered by each sample was
performed at 100× magniﬁcation using the SR ﬁlter set (excitation:
470 nm; emission: 618 nm; Nikon) to assess the total amount of
protein still present after the dual staining procedure. Secondly, ob-
servers were asked to repeat the observation under 1000× magniﬁca-
tion and select 10 areas for sampling and analysis, excluding relatively
big tissue aggregates if present. Images of these areas were then
captured using a CCD camera for both the ThT (excitation: 450 nm;
emission: 480 nm; Nikon) and SYPRO Ruby signals. For each sample
10 areas of interest were used for further analysis.
2.3. Image analysis
Images were analysed using the ImagePro plus software (Media
Cybernetics, Bethesda, MD, USA). To ensure that the sampling was
homogeneous and the same amount of tissue was observed in each
sample, the total amount of protein observed was estimated from
the SR staining. For each experiment, the minimum threshold was
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determined according to the intensity of the ThT signal in the known
negative control. Unknown samples were subsequently analysed
using that set threshold, hence only the stronger characteristic
ﬂuorescence of ThT bound to focal amyloid accumulation was
considered as positive signal by the software. Data in pixels per area
of surface were converted to pg mm−2 according to the estimation of
Fig. 1. Epiﬂuorescence micrographs from thioﬂavin T staining (left column), SYPRO Ruby staining (middle column) and merged pictures (right column) of both; (a–c) NBH before
addition of Tween 20 showing non-speciﬁc binding of ThT to large protein aggregates (red arrows). (d–o) effect of adding Tween 20 to abolish non-speciﬁc binding of ThT to non-
amyloid proteins while showing discrete binding of ThT to small amyloid aggregates present in ME7-containing mixes. This produced the characteristic shift in thioﬂavin T emission
to 482 nm and was clearly distinguishable once corrected for background. Positive areas as assessed by image analysis are indicated by white arrows and circles. Bars: 10 µm.
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Lipscomb et al. (2006b) that a 1 µm-diameter area of protein cor-
responds to approximately 1 pg.
2.4. SDS–PAGE and Western blotting
SDS–PAGE electrophoresis and Western blotting were performed
in parallel with staining and EDIC/EF microscopy to compare the
sensitivity of the two methods for the detection of PrPSc as described
before (Lipscomb et al., 2007). Brieﬂy, the same amount of ME7 and
NBH homogenate mixes (all containing 1 mg ml−1 of protein) that
was applied on tokens was loaded in the gel for comparison (1 µl), i.e.
each lane contained 1 µg of protein from brain homogenate. The
electrophoresis and blotting buffers were obtained from Bio-Rad, UK.
Anonymised samples were subjected to digestion by proteinase K (PK,
Sigma) to a ﬁnal concentration of 10 µg PK per mg of total protein, at
37 °C for 30 min. Samples were boiled for 5 min in loading buffer (2%
SDS, 10% glycerol, 2% β-mercaptoethanol, 0.01% bromophenol blue, in
50mMTris–HCl, pH 6.8) and loaded on a 12% polyacrylamide gel (Bio-
Rad; brain homogenate equivalent to 1 µg of protein per well). After
separation, proteins were transferred onto a PVDF membrane (Bio-
Rad) which was blocked in 5% (w/v) non-fat dry milk in PBS
(Invitrogen) containing 0.1% (v/v) Tween 20 (Sigma) (PBST) for 1 h
at room temperature (as all following steps). PrP was detected using
the monoclonal antibody SAF 60 (CEA, Saclay, France) diluted 1/5000
in PBSTand incubated for 1 h, followed byHRP-conjugated anti-mouse
IgG (1/10,000 in PBST; GE Healthcare, UK) for 1 h. Immunoreactive
bands were visualized using enhanced chemoluminescence (ECL plus,
Amersham Biosciences).
2.5. In situ dual staining on surgical forceps
To assess the applicability of our dual staining procedure in a
clinical context, surgical forceps were cleaned following the same
protocol as that applied to stainless steel tokens, and control images
were taken to assess cleanliness and general state of the instrument.
The forceps were then contaminated by immersing the tip into 10%
ME7-infected brain homogenate (without Tween 20), with a contact
time of less than a second, to simulate potential iatrogenic contami-
nation of the instrument's surface. After letting the instrument dry for
30min, dual stainingwas applied following the exact same protocol as
described above. EDIC/EF images of ThT- and SR-positive signal were
taken at 100× and 1000× magniﬁcation.
2.6. Statistical analysis
Various mixtures of ME7-infected brain homogenate in NBH were
tested on different days and each mixture was tested approximately
10 times. The average amount of positive thioﬂavin T signal observed
for each mixture was plotted against the theoretical ME7 content
(percentage of ME7-infected brain in the mix). Following ANOVA, a t-
test was employed to compare the signal of thioﬂavin T for each ME7
concentration against the NBH reference, and correlation between the
thioﬂavin T signal and the proportion of ME7-infected homogenate
was assessed using the Spearman's rank test in the SPSS package. The
amount of thioﬂavin-positive material observed in various areas from
hamster tissues was compared (t-test) with that of corresponding
negative controls. Values of P≤0.05 were considered signiﬁcant.
3. Results
3.1. Addition of Tween 20 improves recovery and homogenisation of
small amounts of amyloid-infected tissues, facilitating sampling
and observation and improving detection sensitivity
All 10% mice brain homogenates used for this study had a protein
concentration of approximately 16 mg ml−1. Our working protein
concentrationwas normalised to 1mgml−1, i.e. at least 1/16 dilutions
of the original “10%” material. In preliminary experiments we tried to
achieve a dose-related signal to calibrate the assay and determine the
lowest limit of discrimination of amyloid in tissues, using dilutions of
ME7-infected brain in NBH, while maintaining the same ﬁnal protein
concentration of 1 mg ml−1. Following analysis, the thioﬂavin signal
reported by volunteers appeared more elevated in ME7-containing
mixes as expected, though the amount detected in intermediate
dilutions did not correlate with the theoretical amount of PrPSc pre-
sent in the mixture following serial 1/10 dilutions of ME7-infected
brain in NBH. In addition, the total amount of tissues observable ap-
parently varied between different mixes, with relatively large aggre-
gates in some ﬁelds of view and almost no tissues in others. These
discrepancies appeared due to tissue adsorption on the surface of
plastic containers used to prepare the samples and aggregation of
homogenates, which might have been accentuated by the drying
on the stainless steel (Fig. 1a–c). For the purpose of this series of
experiments we added Tween 20 to a ﬁnal concentration of 0.1% (v/v)
in all our normalized brain homogenates prior to distributing and
mixing in anonymised tubes. This resulted in a more homogenous
tissue distribution (Fig. 1, d–o), reduced the number and size of aggre-
gates responsible for elevated background staining, and eventually led
to a better correlation between the ThT signal and the theoretical PrPSc
concentration in the samples (Fig. 2). Since the initial discrepancies
reported with the thioﬂavin staining were associated with the
presence of large tissue aggregates, observers were asked to exclude
any remaining aggregate from subsequent observation and analysis. In
the presence of Tween 20, the total amount of protein available for
observation did not vary signiﬁcantly between the different samples,
as assessed by the SR scan of the whole sample (data not shown).
Protein deposition also appeared under the form of smaller and more
evenly spread particles producing little or no background, allowing
for a better contrasted characteristic ﬂuorescence of ThT bound to
Fig. 2. Thioﬂavin T signal (482 nm) in anonymized samples containing various pro-
portions of ME7-infected brain homogenate. Signal from NBH was set as threshold and
ﬂuorescencemeasured as pixels per total area observed (10 areaswere observed for each
sample) was expressed as pg/mm2. Data are mean±SD of ten separate experiments.
Fig. 3. Comparison of the limit of detection of the same amount of material as that
observed directly under EDIC/EF (Figs. 1 and 2) by classic western blotting. PrP in
various concentrations of ME7-infected brain homogenate prepared into normal brain
homogenate (NBH; down to 0.1% v/v) could be detected prior to Proteinase K (PK)
digestion (lanes 1–4). Following partial digestion with PK (30 min), the signal from a
1 µg mix containing 1% or less ME7-infected homogenate in NBH (lanes 7–8) was not
distinguishable from 1 µg NBH alone (lane 9).
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amyloid, where present. Interestingly, amyloid-positive particles ap-
peared mostly separated from other proteinaceous aggregates,
suggesting that there was no accumulation of other proteins around
these amyloid cores.
In all samples containing at least 0.1% ME7-infected brain homo-
genate, the mean ThT ﬂuorescence (at 482 nm) observed in ten dif-
ferent ﬁelds without aggregates and corrected for background for
image analysis, was signiﬁcantly higher than that of NBH only (Fig. 2;
Pb0.01). Taking into account that (1) the ME7-infected and control
“10% brain homogenates”, appellation based on total weight, were
diluted approximately 16-fold to obtain the working protein concen-
tration of 1mgml−1 (as assessed by protein assay), and (2) volunteers
detected amyloid-positive material in 3-log dilutions of ME7-infected
brain into NBH (the “0.1% mixture”), we can conclude that we
achieved rapid visual detection of characteristic amyloid aggregates
from 1 µg of infected brain homogenate diluted 1/16000 (1/16 dilution
in deionized water followed by 1/1000 dilution in NBH at the same
protein concentration), i.e. 10-100 pg of infected tissue. Furthermore,
volunteers sampled only ten representative areas at 1000× magniﬁca-
tion for image analysis, which corresponded to a small fraction of the
whole sample, therefore we can estimate the detection level of this
dual staining method to be in the nanogram range, without the need
of intermediate ampliﬁcation steps. Some of the anonymised samples
were NBH only to assess the risk of false positives. Reported levels of
ThT signal in 0.01% ME7-infected brain mixtures were undistinguish-
able from the background signal observed in negative controls using
our image analysis software (data not shown). When PrPSc could be
detected andmeasured, we obtained a positive correlation (Spearman's
rho=0.896) between the ThT signal and the theoretical concentration
of PrPSc in the samples.
Fig. 4. Epiﬂuorescence micrographs of dual stained ME7-infected brain homogenate contamination on two different areas of surgical forceps; (a and b) SYPRO Ruby staining, (c and
d) thioﬂavin T staining, (e and f) merged pictures of both staining, (g and h) pictures of staining combined with EDIC white light image of the instrument. Bars: 100 µm.
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3.2. Sensitivity of the dual staining method remains at least 2-log higher
than that of Western blot using the same samples
PrP was detected in all samples prior to partial PK digestion, using
only 1 µg of tissue per lane (Fig. 3, lanes 1–4). Following partial diges-
tion with PK, the samples containing ME7 only produced clear bands
characteristic of PrPSc (Fig. 3, lane 5). The mixes containing 10% ME7
(v/v, equivalent to 0.1 µg of protein from ME7 brain) rarely produced
visible bands (Fig. 3, lane 6), whereas the 1% or 0.1% ME7 mixes
(v/v, equivalent to 10 ng of protein from ME7 brain) were never dis-
tinguishable from the NBH control (Fig. 3, lanes 7–9).
3.3. Detection of contamination on spiked surgical instruments
Biopsy forceps artiﬁcially contaminated and left to dry for 30 min,
as might happen in a clinical setting, could be readily stained and
contamination observed using EDIC/EF microscopy. After the forceps
were put brieﬂy (less than a second) in contact with ME7-infected
brain homogenate, general contamination was observed at 100×
magniﬁcation (Fig. 4). Interestingly, ThT-positive material could be
distinguished from general protein contamination under 1000×
magniﬁcation (Fig. 5). Protein contamination was mostly present
in the indented areas of the instrument, as well as in the grooves
naturally present on the stainless steel surface. On average 47.2 µg
of tissue protein and 642.6 pg of PrPSc amyloid had bound per mm2 of
the instrument surface, even in less than one second contact time.
4. Discussion
4.1. The preparation and handling of samples is critical for the detection
of amyloid aggregates in samples containing low amounts of PrPSc
Most samples of brain homogenates are prepared in PBS and
stored in plastic containers, which might be detrimental to the
Fig. 5.Highmagniﬁcation epiﬂuorescencemicrographs of dual stainedME7-infected brain homogenate contamination on twodifferent areas of surgical forceps; (a and b) SYPRORuby
staining, (c and d) thioﬂavin T staining, (e and f) merged pictures of both staining, (g and h) pictures of staining combined with EDIC white light image of the instrument. Bars: 10 µm.
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detection of low levels of PrPSc due to its hydrophobic nature and
tendency to adhere strongly to surfaces. This renders detection and
precise quantiﬁcation of amyloid content difﬁcult in samples contain-
ing low amounts of infected material, and only the highest concen-
trations (greater than 50%mixes, i.e. containing at least 0.5 µg of ME7-
infected material) were clearly “positive” in our observations (data
not shown). In addition, the aggregation of tissue is likely to vary
between different species and different tissues, and this is an inherent
risk of misidentiﬁcation. Other studies have reported the inﬂuence of
the interactions between lipids and PrP in terms of both neurotoxicity
(Wang et al., 2006) and conformation changes (Wang et al., 2007).
Interestingly, Deleault et al. (2007) were able to synthesize de novo
infectious PrPSc molecules by protein misfolding cyclic ampliﬁcation,
using simply native PrPC molecules in the presence of copuriﬁed lipid
molecules and a synthetic polyanion. Interactions between prion amy-
loid and tissue lipids in PBS-diluted homogenates are likely to affect
the detection of PrP in its different conformations from lipid-rich
tissues such as brain. The addition of Tween 20 to all homogenate
samples prepared for the calibration improved the recovery of the
prion-containing fractions of brain homogenate from plastic Eppen-
dorf tubes and pipette tips during the preparation of serial dilutions,
as assessed by the clearer ThT and SR signals under the microscope for
the same volumes of samples. This might be of relevance to other
methods involving the preparation and storage of small volumes
of PrPSc sample in plastic containers and their subsequent use in
quantitative assays.
We found that ThT was prone to produce a relatively high back-
ground signal in aggregates of tissue on heavily soiled surfaces, albeit
at a lower emission wavelength than for prion amyloid plaques. Al-
though the addition of Tween 20 did not totally prevent aggregation to
somedegree, the improvedhomogeneityand the selection of aggregate-
free areas for analysis allowed eliminating virtually all elevated back-
ground created by relatively thick tissue lumps left in the samples. This
stronger signal in aggregates was observed for all wavelengths used,
and the SR staining discriminated and helped to conﬁrm when an
apparently strong ThT signal was in fact higher background created by
thicker aggregates of tissues in the homogenate.
Despite the difﬁculties inherent to the use of ThT reported else-
where (Nilsson, 2004) and the very low amounts of impure material
examined with the present technique, we observed a positive correla-
tion between the ThT signal and the expected relative amount of PrPSc
in these speciﬁcally prepared samples. Double-blind studies produced
a dose-related signal on contaminated surgical stainless steel surfaces
down to 3-log dilutions of ME7-infected brain into normal homo-
genates, as assessed by image analysis. Our level of detection using
Western blot was similar to what we reported before (Lipscomb et al.,
2007) or those reported elsewhere (Wadsworth et al., 2001; Beekes
et al., 1995) and equates to at least a 2-log lower sensitivity of detec-
tion compared to the ThT/SR dual stain procedure described above,
when applied to the same amount of material (1 µg total protein).
Sensitive Western blotting assays using sodium phosphotungstic
acid precipitation have been reported to allow the detection of PrPSc
from 5 nl of 10% vCJD brain homogenate (Wadsworth et al., 2001).
This equates to 500 ng of tissue prior to PK digestion. In accordance
with these data, in our studies PrPSc could not be detected byWestern
blot beyond a 1/10 dilution of 1 µg of 10% ME7-infected brain diluted
in normal brain homogenate (i.e. 100 ng of ME7-infected homo-
genate). In contrast, the dual staining procedure allowed detection
down to less than 1 ng of ME7-infected homogenate. Interestingly, the
fact that amyloid-positive material appeared clearly dissociated from
other proteinaceous deposition in all prepared dilutions conﬁrms that
the dual staining procedure is clearly discriminating between amyloid
and general tissue proteins.
As we discussed previously when reporting results using thiazole
reagents alone (Lipscomb et al., 2007), it has to be noted that ThT is
capable of detecting various forms of amyloid aggregations, which
therefore does not preclude its application to amyloidogenic prion
diseases, but also potentially includes Alzheimer's disease and other
amyloidoses. ThT has also been successfully used to detect amyloid
adhesins in bacterial bioﬁlms (Larsen et al., 2007) and in more
complex mixtures such as sludge ﬂocs from wastewater treatment
plants (Larsen et al., 2008). The presence of such bacterial compo-
nents in tissues is unlikely, but bacterial bioﬁlms are not uncommon
on the surface of some surgical instruments, or inside the lumen of
endoscopes. The present method has potential for pathological
studies, and also routine surveillance of tissues or surgical instruments
(see below). It does not allow the identiﬁcation of a particular
amyloidosis or prion strain, as other methods might do. However
other methods such as Western blot require more material to produce
a clear result, therefore more complex intermediate steps such as
protein misfolding cyclic ampliﬁcation (PMCA; Saborio et al., 2001)
are required. Our method trades strain speciﬁcity for sensitivity, low
cost of consumables involved, ease of use and rapidity.
4.2. This technique offers great potential to rapidly assess the
decontamination of surgical instruments, with quantitative
discrimination between amyloid and other protein deposits
Our direct observation technique allows us to observe the inside of
grooves and other areas on a surgical instrument, otherwise difﬁcult
to swab. The sensitivity of our method is likely to be even greater than
demonstrated here since testing instrument surfaces by Western blot
relies on swabbing the contaminated surface, and PrPSc is known to
bind strongly to surfaces. Here we have not tried to elute or swab the
1 µl contamination to assess how much could be recovered for
Western blot, however our experience is that amyloid is difﬁcult to
remove from the surfaces it has attached upon, and evenmore difﬁcult
to transfer back integrally into another container or onto another
support.
As we reported before using a single ThT staining procedure
(Lipscomb et al., 2007), the new ThT/SR dual staining procedure
allowed visualisation and discrimination of very low levels of amyloid
and other proteinaceous contamination on surgical instruments.
Worryingly, measurements from the whole instrument converted to
mass (Lipscomb et al., 2006b) revealed approximately 47.2 µg of tissue
protein and 642.6 pg of PrPSc amyloid per mm2 of the instrument
surface after only one second contact time. This level of amyloid
contamination equates to 18 femtomoles of PrPSc per mm2 and is of
concern since this could represent many infectious doses. Clearly,
even brief surgical procedures on infected patients may lead to the
binding of prion amyloid to instrument surfaces, and present a risk of
iatrogenic transmission if the instruments are not successfully
cleaned. Both general tissue protein and prion amyloid contamination
tended to aggregate in grooves or pits present on the surface of the
instrument, which would make their removal more difﬁcult. Although
no Tween 20 was added for these experiments, thioﬂavin-positive
deposits could be clearly distinguished from other proteins. These
results suggest that general tissue proteins do not tend to aggregate
around amyloid cores. Alternatively, some amyloid material could be
masked by the accumulation of non-amyloid proteins around an
amyloid core, preventing the binding of ThT. However, no large aggre-
gates were found to adhere on the surface of the instruments, since
these tended to be washed away during simple rinsing procedures,
and only small particles remained in grooves and pits. Further studies
shall investigate how the concentration of amyloid and other molec-
ular constituents inﬂuence the binding capacity of the tissue. Similarly,
this technique offers great potential to rapidly assess cleaning chem-
istries andmethods of decontamination of surgical instruments in situ,
without introducing less sensitive swabbing or removal artefacts.
It has been reported that amyloid accumulation can be observed in
aging individuals, independently of any pathology (Rowe et al., 2007).
A baseline of “normal amyloid content” might need to be established
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for such sensitive methods, which can be achieved by numerous
observations of non-diseased brain, and potentially other tissues. The
thiazole dyes do not discriminate between amyloid plaques composed
of PrPSc and plaques that might be composed of other amyloidogenic
ﬁbrils such asAβ, amajor component of Alzheimer's disease pathology.
The possibility that Aβﬁbrilsmayalso display some infectivity (Meyer-
Luehmann et al., 2006; Riek, 2006), even if such transmission is highly
unlikely and of a different nature to prion disease, must raise concern
over any surface-bound amyloid contamination that may be found on
an instrument.
We tried to establish a standard curve using recombinant PrP in
the same conditions, but the puriﬁed material we used did not adhere
sufﬁciently on the stainless steel surface and was mostly washed out,
thus only a few particles were observed (data not showed). Fortu-
nately, the present method can be used to quantify the concentration
of PrPSc amyloid directly in infected brain and other tissues without
resorting to reference standards. Those recombinant molecules are
often not identical to the protein in its native state in diseased tissues,
and therefore might present different detectability characteristics.
5. Conclusion
This new sensitive microscopy procedure is rapid and can be
applied directly to instrument surfaces to discriminate and measure
amyloid and general tissue proteins contamination. As such, it offers a
simple way to assess current protocols for instrument decontamina-
tion in washer/disinfector systems of sterile service departments,
which should contribute to reducing the risk of iatrogenic transmis-
sion of CJD and other proteinaceous infectious agents. ThT/SR dual
staining may also be used as such as a quantitative analysis tool to
detect abnormal levels of amyloid aggregation in small samples of
tissues and may offer an alternative method for rapid screening of
biopsy samples.
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